Sildenafil citrate as oral solid lipid nanoparticles: a novel formula with higher bioavailability and sustained action for treatment of erectile dysfunction

Bibliography

• Jung Y, Seo G, Kim G, et al. Comparison of the solubility and pharmacokinetics of Sildenafil citrate salts. Arch Pharm Res 2011;34(3):451-4
   PubMed Web of Science ®Google Scholar
• Webb J, Freestone S, Allen J, et al. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist. Am J Cardiol 1999;83:21-8
   PubMed Web of Science ®Google Scholar
• Shin S, Bae K, Lee G. Pharmacokinetics of Sildenafil citrate after intravenous and oral administration in rats: hepatic and intestinal first-pass effects. Int J Pharm 2006;320:64-70
   PubMed Web of Science ®Google Scholar
• Fraisse A, Butrous G, Taylor M, et al. Intravenous Sildenafil citrate for postoperative pulmonary hypertension in children with congenital heart disease. Intensive Care Med 2011;37(3):502-9
   PubMed Web of Science ®Google Scholar
• Wang Y, Chow S, Zuo Z. Mechanistic analysis of pH-dependent solubility and trans-membrane permeability of Amphoteric compounds: application to Sildenafil citrate. Int J Pharm 2008;352:217-24
   PubMed Web of Science ®Google Scholar
• Harde H, Das M, Jain S. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle. Expert Opin Drug Deliv 2011;8(11):1407-24
   PubMed Web of Science ®Google Scholar
• Pandey R, Sharma S, Khuller GK. Oral solid lipid nanoparticle-based antitubercular chemotherapy. Tuberculosis (Edinb) 2005;85:415-20
   PubMed Web of Science ®Google Scholar
• Münster U, Nakamura C, Haberland A, et al. RU 58841-Myristate-prodrug development for topical treatment of acne and Androgenetic Alopecia. Pharmazie 2005;60(1):8-12
   PubMed Web of Science ®Google Scholar
• Wissing SA, Kayser O, Müller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 2004;56(9):1257-72
   PubMed Web of Science ®Google Scholar
• Cavalli R, Gasco MR, Chetoni P, et al. Solid lipid nanoparticles (SLN) as ocular delivery system for Tobramycin. Int J Pharm 2002;238:241-5
   PubMed Web of Science ®Google Scholar
• Sznitowska M, Gajewska M, Janicki S, et al. Bioavailability of Diazepam from aqueous-organic solution, Submicron emulsion and solid lipid nanoparticles after rectal administration in rabbits. Eur J Pharm Biopharm 2001;52(2):159-63
   PubMed Web of Science ®Google Scholar
• Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery II. Drug Incorporation and physicochemical characterization. J Microencapsul 1999;16(2):205-13
   PubMed Web of Science ®Google Scholar
• Dingler A, Gohla S. Production of solid lipid nanoparticles (SLN): scaling up feasibilities. J Microencapsul 2002;19(1):11-16
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mäder K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 2001;47:165-96
   PubMed Web of Science ®Google Scholar
• Luo Y, Chen D, Ren L, et al. Solid lipid nanoparticles for enhancing Vinpocetine's oral bioavailability. J Control Release 2006;114(1):53-9
   PubMed Web of Science ®Google Scholar
• Zhang N, Ping Q, Huang G, et al. Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin. Int J Pharm 2006;327:153-9
   PubMed Web of Science ®Google Scholar
• Göppert TM, Müller RH. Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting. Int J Pharm 2005;302:172-86
   PubMed Web of Science ®Google Scholar
• Kamble S, Vaidya K, Bhosale V, et al. Solid lipid nanoparticles and nanostructured lipid carriers–an overview. Int J Pharma chemical Biolog Sci 2012;2(4):681-91
   Google Scholar
• Ekambaram P, Sathali H, Priyanka K. Solid lipid nanoparticles: a review. Sci Rev Chem Commun 2012;2(1):82-5
   Google Scholar
• Sinha VR, Srivastava S, Goel H, et al. Solid lipid nanoparticles (SLN’s)- trends and implications in drug targeting. Int J Adv Pharm Sci 2010;1:212-38
   Google Scholar
• Cortesi R, Esposito E, Luca G, et al. Production of Lipospheres as carriers for bioactive compounds. Biomaterials 2002;23(11):2283-94
   PubMed Web of Science ®Google Scholar
• Song C, Liu S. A new healthy sunscreen system for human: solid lipid nannoparticles as carrier for 3,4,5-trimethoxybenzoylchitin and the improvement by adding Vitamin E. Int J Biol Macromol 2005;36:116-19
   PubMed Web of Science ®Google Scholar
• Ahlin P, Kristl J, Smid-Kobar J. Optimization of procedure parameters and physical stability of solid lipid nanoparticles in dispersions. Acta Pharmaceutica 1998;48:257-67
   Google Scholar
• Joshi M, Patravale V. Formulation and evaluation of nanostructured lipid carrier (NLC)-based gel of Valdecoxib. Drug Dev Ind Pharm 2006;32:911-18
   PubMed Web of Science ®Google Scholar
• Chen CC, Tsai TH, Huang ZR, et al. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. Eur J Pharm Biopharm 2010;74:474-82
   PubMed Web of Science ®Google Scholar
• Elshafeey A, Bendas E, Mohamed O. Intranasal microemulsion of sildenafil citrate: in vitro evaluation and in vivo pharmacokinetic study in rabbits. AAPS PharmSciTech 2009;10(2):361-7
   PubMed Web of Science ®Google Scholar
• Meyyanathan SN, Muralidharan S, Rajan S, et al. A simple sample preparation with HPLC–UV method for estimation of amlodipine from plasma: application to bioequivalence study. Open Chem Biomed Meth J 2008;1:22-7
   Google Scholar
• Yang Z, Gao S, Wang J, et al. Enhancement of oral bioavailability of 20(S)-ginsenoside Rh2 through improved understanding of its absorptionand efflux mechanisms. Drug Metab Dispos 2011;39:1866-72
   PubMed Web of Science ®Google Scholar
• Battaglia L, Trotta M, Gallarate M, et al. Solid lipid nanoparticles formed by solvent-in-water emulsion–diffusion technique: development and influence on insulin stability. J Microencapsul 2007;24:672-84
   Web of Science ®Google Scholar
• Sanna V, Caria G, Mariani A. Effect of lipid nanoparticles containing fatty alcohols having different chain length on the ex vivo skin permeability of econazole nitrate. Powder Technol 2010;201:32-6
   Web of Science ®Google Scholar
• Shah KA, Date AA, Joshi MD, et al. Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int J Pharm 2007;345:163-71
   PubMed Web of Science ®Google Scholar
• Tanvir S, Qiao L. Surface tension of nanofluid-type fuels containing suspended nanomaterials. Nanoscale Res Lett 2012;7:226
   PubMedGoogle Scholar
• Uner M, Wissing SA, Yener G, et al. Influence of surfactants on the physical stability of solid lipid nanoparticle (SLN) formulations. Pharmazie 2004;59:331-2
   PubMed Web of Science ®Google Scholar
• Westesen K, Siekmann B, Koch MHJ. Investigations on the physical state of lipid nanoparticles by synchrotron X-ray diffraction. Int J Pharm 1993;93:189-99
   Web of Science ®Google Scholar
• Das S, Ng WK, Tan RB. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur J Pharm Sci 2012;47:139-51
   PubMed Web of Science ®Google Scholar
• Yassin AE, Anwar MK, Mowafy HA, et al. Optimization of 5-fluorouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer. Int J Med Sci 2010;7:398-408
   PubMed Web of Science ®Google Scholar
• Liu J, Gong T, Wang C, et al. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization. Int J Pharm 2007;340:153-62
   PubMed Web of Science ®Google Scholar
• Yang Q, Owusu-Ababio G. Biodegradable progesterone microsphere delivery system for osteoporosis therapy. Drug Dev Ind Pharm 2000;26:61-70
   PubMed Web of Science ®Google Scholar
• Surajit D, Wai K, Parijat K, et al. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables. Colloids Surf B Biointerfaces 2011;88:483-9
   PubMed Web of Science ®Google Scholar
• Yosra E, Magda E, Ossama A. Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles. Int J Nanomedicine 2011;6:3195-205
   PubMed Web of Science ®Google Scholar
• Chen B, Yang Z, Lu L, Zhang Q. In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel. Chem Pharm Bull 2001;49(11):1444-7
   PubMed Web of Science ®Google Scholar
• Doijad C, Marvi V, Deshmukh V. Formulation and targeting efficiency of cisplatin engineered solid lipid nanoparticles. Int J Pharm 2008;70:203-7
   Google Scholar
• Araujo L, Sheppard M, L¨obenberg R, et al. Uptake of PMMA nanoparticles from the gastrointestinal tract after oral administration to rats: modification of the body distribution after suspension in surfactant solutions and in oil vehicles. Int J Pharm 1999;176:209-24
   Web of Science ®Google Scholar